Global X Cannabis ETF News

The week ending in February 15 featured the Exchange conference in Miami, Florida, and launches were muted as a result. Only one new ETF made its debut during the week.

One of the top-performing thematic segments this year is cannabis. A major catalyst has been the proposed descheduling of it from a Schedule I to a Schedule III drug under the Controlled Substances Ac

Support for cannabis legalization reached all-time highs in 2023, creating a long list of cannabis stocks to buy. For one, a new Gallup survey found that 70% of Americans believe cannabis should be

So far this month, Wall Street remained almost flat. But a few ETF areas have been hovering at around a month-high and have been still gaining strength.

Cannabis stocks will eventually see higher highs — with patience. Right now, we're waiting to see if the Drug Enforcement Administration (DEA) takes the U.S. Department of Health and Human Service

Cannabis stocks may be one of the most controversial trades on the market. But it could also turn out to be one of the most profitable.

Like any recovering reporter, I like to keep tabs on my old beats, and the marijuana ETF space never disappoints. Or, perhaps more accurately, it never stops disappointing.

Cannabis stocks are in focus after the Secure and Fair Enforcement Regulation Banking Act moved forward in the upper chamber of Congress on Wednesday. What the renegotiated SAFER means for cannabis co

Cannabis is now the sixth most valuable crop in the United States, with an estimated 2022 harvest value of $5 billion. Over the last 52 weeks, the Global X Cannabis ETF is down roughly 52%. The global

Investing and trading cannabis stocks has been extraordinarily difficult. I feel for those who took a bet for all the right reasons (which we'll get into).

The prospect of marijuana reclassification has injected newfound optimism into the cannabis investment landscape.

The move by the Drug Enforcement Administration to review the Schedule I classification for cannabis sparked a wave of speculation and mostly positive comments from Wall Street on Thursday, but many q

Wall Street delivered a decent-to-upbeat performance last week.

POTX invests mainly in healthcare and real estate institutions that are focused on cannabis. The demand for and spending towards cannabis is increasing, but many dispensaries and cannabis-focused inst

Cannabis ETFs began to hit the market in 2017. As cannabis stocks have declined, they have lost their popularity.